Literature DB >> 10191052

Retinoid signaling is required for chondrocyte maturation and endochondral bone formation during limb skeletogenesis.

E Koyama1, E B Golden, T Kirsch, S L Adams, R A Chandraratna, J J Michaille, M Pacifici.   

Abstract

Retinoids have long been known to influence skeletogenesis but the specific roles played by these effectors and their nuclear receptors remain unclear. Thus, it is not known whether endogenous retinoids are present in developing skeletal elements, whether expression of the retinoic acid receptor (RAR) genes alpha, beta, and gamma changes during chondrocyte maturation, or how interference with retinoid signaling affects skeletogenesis. We found that immature chondrocytes present in stage 27 (Day 5.5) chick embryo humerus exhibited low and diffuse expression of RARalpha and gamma, while RARbeta expression was strong in perichondrium. Emergence of hypertrophic chondrocytes in Day 8-10 embryo limbs was accompanied by a marked and selective up-regulation of RARgamma gene expression. The RARgamma-rich type X collagen-expressing hypertrophic chondrocytes lay below metaphyseal prehypertrophic chondrocytes expressing Indian hedgehog (Ihh) and were followed by mineralizing chondrocytes undergoing endochondral ossification. Bioassays revealed that cartilaginous elements in Day 5.5, 8.5, and 10 chick embryo limbs all contained endogenous retinoids; strikingly, the perichondrial tissues surrounding the cartilages contained very large amounts of retinoids. Implantation of beads filled with retinoid antagonist Ro 41-5253 or AGN 193109 near the humeral anlagens in stage 21 (Day 3.5) or stage 27 chick embryos severely affected humerus development. In comparison to their normal counterparts, antagonist-treated humeri in Day 8.5-10 chick embryos were significantly shorter and abnormally bent; their diaphyseal chondrocytes had remained prehypertrophic Ihh-expressing cells, did not express RARgamma, and were not undergoing endochondral ossification. Interestingly, formation of an intramembranous bony collar around the diaphysis was not affected by antagonist treatment. Using chondrocyte cultures, we found that the antagonists effectively interfered with the ability of all-trans-retinoic acid to induce terminal cell maturation. The results provide clear evidence that retinoid-dependent and RAR-mediated mechanisms are required for completion of the chondrocyte maturation process and endochondral ossification in the developing limb. These mechanisms may be positively influenced by cooperative interactions between the chondrocytes and their retinoid-rich perichondrial tissues. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10191052     DOI: 10.1006/dbio.1999.9207

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  40 in total

Review 1.  Matrix vesicles and calcification.

Authors:  H Clarke Anderson
Journal:  Curr Rheumatol Rep       Date:  2003-06       Impact factor: 4.592

2.  Synovial joint formation requires local Ext1 expression and heparan sulfate production in developing mouse embryo limbs and spine.

Authors:  Christina Mundy; Tadashi Yasuda; Takashi Kinumatsu; Yu Yamaguchi; Masahiro Iwamoto; Motomi Enomoto-Iwamoto; Eiki Koyama; Maurizio Pacifici
Journal:  Dev Biol       Date:  2010-12-23       Impact factor: 3.582

3.  Retinoic Receptor Signaling Regulates Hypertrophic Chondrocyte-specific Gene Expression.

Authors:  Tsuyoshi Shimo; Eiki Koyama; Tatsuo Okui; Masanori Masui; Yuki Kunisada; Soichiro Ibaragi; Norie Yoshioka; Naito Kurio; Shoko Yoshida; Akira Sasaki; Masahiro Iwamoto
Journal:  In Vivo       Date:  2019 Jan-Feb       Impact factor: 2.155

4.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease.

Authors:  Ian D Welch; Matthew F Cowan; Frank Beier; Tully M Underhill
Journal:  Arthritis Res Ther       Date:  2009-01-28       Impact factor: 5.156

Review 5.  Osteochondromas: An Updated Review of Epidemiology, Pathogenesis, Clinical Presentation, Radiological Features and Treatment Options.

Authors:  Kostas Tepelenis; Georgios Papathanakos; Aikaterini Kitsouli; Theodoros Troupis; Alexandra Barbouti; Konstantinos Vlachos; Panagiotis Kanavaros; Panagiotis Kitsoulis
Journal:  In Vivo       Date:  2021 Mar-Apr       Impact factor: 2.155

6.  Perichondrium phenotype and border function are regulated by Ext1 and heparan sulfate in developing long bones: a mechanism likely deranged in Hereditary Multiple Exostoses.

Authors:  Julianne Huegel; Christina Mundy; Federica Sgariglia; Patrik Nygren; Paul C Billings; Yu Yamaguchi; Eiki Koyama; Maurizio Pacifici
Journal:  Dev Biol       Date:  2013-03-01       Impact factor: 3.582

7.  A distinct cohort of progenitor cells participates in synovial joint and articular cartilage formation during mouse limb skeletogenesis.

Authors:  Eiki Koyama; Yoshihiro Shibukawa; Motohiko Nagayama; Hiroki Sugito; Blanche Young; Takahito Yuasa; Takahiro Okabe; Takanaga Ochiai; Nobuhiko Kamiya; Ryan B Rountree; David M Kingsley; Masahiro Iwamoto; Motomi Enomoto-Iwamoto; Maurizio Pacifici
Journal:  Dev Biol       Date:  2008-01-26       Impact factor: 3.582

8.  Retinoic acid receptors are required for skeletal growth, matrix homeostasis and growth plate function in postnatal mouse.

Authors:  Julie A Williams; Naoki Kondo; Takahiro Okabe; Nobuo Takeshita; Diane M Pilchak; Eiki Koyama; Takanaga Ochiai; Deborah Jensen; Mon-Li Chu; Maureen A Kane; Joseph L Napoli; Motomi Enomoto-Iwamoto; Norbert Ghyselinck; Pierre Chambon; Maurizio Pacifici; Masahiro Iwamoto
Journal:  Dev Biol       Date:  2009-02-03       Impact factor: 3.582

9.  Retinoic acid and the transcription factor MafB act together and differentially to regulate aggrecan and matrix metalloproteinase gene expression in neonatal chondrocytes.

Authors:  Yao Zhang; A Catharine Ross
Journal:  J Cell Biochem       Date:  2013-02       Impact factor: 4.429

10.  Retinoic acid signaling organizes endodermal organ specification along the entire antero-posterior axis.

Authors:  Elke Bayha; Mette C Jørgensen; Palle Serup; Anne Grapin-Botton
Journal:  PLoS One       Date:  2009-06-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.